‘Wait-and-See Time’: Panel Predicts Limited Congressional Action On Devices This Year

An expert panel at the FDLI annual meeting expects the US Congress to want to see more results from recent legislation on devices before it moves ahead with further FDA reform. Though, pandemic-related measures remain a priority.  

US Capitol, Washington DC (f11photo/Shutterstock.com)

More from Legislation

More from Policy & Regulation